2023 annual financial data
Fennec Pharmaceuticals 2023 Operating margin
Fennec Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -61.44%.
Operating income was -13,058,000 USD and net income was -16,045,000 USD.
Operating cash flow was -17,143,000 USD.
Get free Fennec Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 21,252,000 USD
- Operating income
- -13,058,000 USD
- Net income
- -16,045,000 USD
- Operating cash flow
- -17,143,000 USD